Japan Tissue Engineering Co., Ltd. (7774)

Overview

Japan Tissue Engineering Co., Ltd., operational since 1999 and located in Gamagori, Japan, stands at the forefront of the regenerative medicine industry within the country. With a primary focus on regenerative medicine, the company has established itself through its diverse operations categorized into three main segments: Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support. It aligns itself with the purpose of advancing medical treatment through specialized tissue-engineered products and services. Further consolidating its position in the industry, it operates as a subsidiary of Teijin Limited, a testament to its established credibility and innovative edge in the field of bioscience.

Products and Services

The array of offerings from Japan Tissue Engineering Co., Ltd. reflects its commitment to addressing a spectrum of medical needs through regenerative medicine. Each product and service is developed with meticulous research and a patient-centric approach:

• Autologous Cultured Epidermis: This product is designed for patients suffering from skin diseases or injuries. It utilizes the patient's own skin cells to grow new epidermis layers in a lab setting, offering a tailored solution for skin restoration.
• Cultured Cartilage: Developed for individuals with cartilage damage or degeneration. The cultured cartilage provides a viable option for regenerating damaged cartilage, particularly beneficial in joint repair and arthritis management.
• Cultured Corneal Epithelium: Aimed at restoring vision or treating corneal surface diseases. This product uses a patient’s own cells to regenerate the corneal epithelium, showcasing the incredible potential of regenerative medicine in ophthalmology.
• Cultured Oral Mucosal Epithelium: This is focused on addressing oral health issues by regenerating oral mucosa, thus aiding in the healing of various oral wounds and conditions with a minimally invasive approach.
• Tissue-Engineered Medical Products: A line of products expanding beyond skin, cartilage, and corneal applications, catering to more specialized medical needs that require innovative, tissue-engineering solutions.
• Human 3-Dimensional Cultured Tissue Models: These are developed for cosmetic and pharmaceutical testing, replacing traditional animal models with human tissues for more accurate and ethical research outcomes. These models are integral in drug development and cosmetic safety testing, embodying the shift towards more reliable and humane research methodologies.
• Regenerative Medicine Contract Development and Manufacturing Services: Beyond product development, Japan Tissue Engineering Co., Ltd. extends its expertise through contract services that support other organizations in the development and manufacturing of regenerative medicine solutions. This encompasses a comprehensive suite of services tailored to bring novel therapies from bench to bedside efficiently.